As companies around the world scramble to develop a vaccine against the new strain of coronavirus, now known as SARS-CoV-2, Codagenix Inc. Inc., a US-based clinical-stage biotechnology company, along with partner Serum Institute of India Ltd., is throwing its hat in the ring.
Codagenix develops prophylactic vaccines and oncolytic virus therapies while India-based Serum is the world's largest vaccine manufacturer by number of...






